EIP hires Teva litigator
EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Jones (pictured) joins EIP’s London office as part of the IP litigation practice EIP Legal, which is headed by partner Gary Moss. Moss previously worked with Jones at McDermott Will & Emery and Taylor Wessing LLP.
He said of Jones: “He is a highly experienced IP lawyer and his areas of technical expertise complement those of the current EIP Legal team.
“Coupled with our newly established office in the US and the future German office, this further strengthens our abilities to handle major litigation cases on a multi-jurisdictional basis.”
Jones was involved in litigation related to blockbuster drug Copaxone fought between Teva and Mylan, and has also acted in cases related to electronics, telecommunications, cryptography, optics and mechanical devices.
He is particularly experienced in the pharmaceuticals and biotechnology fields.
Jones said he was “thrilled” to be joining EIP: “EIP’s virtually unique combination of IP litigators and patent and trademarks attorneys brings, I believe, significant advantages for clients in this area which I am eager to exploit.”
He added that he is looking forward to renewing his working relationship with Moss.
EIP has 18 partners based in five offices in the UK and US. It recently announced it will open a sixth office in Düsseldorf, Germany.
